Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium-Reference-Cited by-同舟云学术

Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

Published:2008-08-01 Issue:4 Volume:10 Page:631-642
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Chang Susan M.,Lamborn Kathleen R.,Kuhn John G.,Yung W.K. Alfred,Gilbert Mark R.,Wen Patrick Y.,Fine Howard A.,Mehta Minesh P.,DeAngelis Lisa M.,Lieberman Frank S.,Cloughesy Timothy F.,Robins H. Ian,Abrey Lauren E.,Prados Michael D.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/10/4/631/13065066/NO104_15_Chang.pdf

Reference45 articles.

1. Chang SM, Wen P, Cloughesy T, et al. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs. 2005;23: 357-361.

2. Cloughesy TF, Wen PY, Robins HI, et al. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2006;24: 3651-3656.

3. Wen PY, Yung WK, Lamborn KR, et al. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res. 2006;12: 4899-4907.

4. Fox E, Curt GA, Balis FM. Clinical trial design for target-based therapy. Oncologist. 2002;7: 401-409.

5. Ma BB, Britten CD, Siu LL. Clinical trial designs for targeted agents. Hematol Oncol Clin North Am. 2002;16: 1287-1305.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR);Cell Reports Medicine;2024-07

2. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT;Clinical Cancer Research;2024-06-05

3. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study;BMC Medicine;2023-07-05

4. Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review;Neuro-Oncology;2020-06-29

5. Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients;Medicine;2017-03